Notes on AI, drug discovery, and building platforms in biomedicine. Short posts. No listicles. Occasional diagrams.
Two digital twin prototypes, two very different domains, one question — when does a synthetic trajectory earn the right to influence a decision? Notes on what it took to get to ±0.3% HbA1c over 56 weeks, and what the same backbone looks like in consumer behaviour.
